PANJON.BO stock up 19.99% pre-market on 23 Jan 2026: watch volume

PANJON.BO stock up 19.99% pre-market on 23 Jan 2026: watch volume

PANJON.BO stock leads pre-market gainers after a 19.99% intraday rise to INR 24.61 on the BSE on 23 Jan 2026. Trading opened at INR 20.50 and the stock hit a pre-market high of INR 24.61 on a volume spike of 170,620 shares, well above the average volume of 14,086.00. This move makes Panjon Ltd. one of the top gainers in the Healthcare (Medical – Pharmaceuticals) group in India. We review fundamentals, technicals, the Meyka AI grade and model forecasts to explain the jump and outline near-term levels to watch.

Price action and market context for PANJON.BO stock

PANJON.BO stock is trading at INR 24.61, up 19.99% from the previous close of INR 20.51. The intraday range shows a low of INR 20.50 and a high of INR 24.61, with relative volume of 12.11 indicating heavy retail or momentum buying. Market cap stands at INR 422,418,985.00 and shares outstanding are 17,164,526.00, keeping the company a small-cap name on the BSE in India.

Fundamentals and valuation: PANJON.BO analysis

Panjon Ltd. reports EPS INR 0.42 and a trailing PE of 58.60, highlighting valuation stretch versus profit. Price-to-sales is 0.91 and price-to-book is 2.50, with book value per share at INR 9.82. Current ratio is strong at 2.75, debt-to-equity is 0.21, and return on equity is 4.62%, which points to conservative balance-sheet risk but modest profitability.

Technical setup and trading signals for PANJON.BO stock

Short-term technicals show an RSI of 48.17 and ADX 39.25 indicating a strong trend in play. The stock’s 50-day average is INR 17.55 and 200-day average is INR 18.82, so current price is well above averages, confirming momentum. Watch support near INR 20.50 and immediate resistance at the 52-week high INR 26.57.

Meyka AI grade and model forecasts for PANJON.BO stock

Meyka AI rates PANJON.BO with a score out of 100: 61.34 out of 100 — Grade B, HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of INR 24.16 versus the current INR 24.61, implying a model-based downside of -1.86%. Forecasts are model-based projections and not guarantees.

Catalysts, sector context and risks

Panjon operates in Healthcare (Medical – Pharmaceuticals) where peers trade at higher average P/E near 39.27 for the sector; Panjon’s small-cap status leaves it more sensitive to volume and news. Catalysts that could sustain gains include trade or distributor expansion, product launches, or improving margins. Key risks are thin liquidity, high trailing PE of 58.60, narrow net margins at 1.61%, and limited free cash flow visibility.

Trading approach and price targets for PANJON.BO stock

Analyst-consensus style trading favors staging buys on pullbacks to support. We set a conservative near-term price target of INR 25.50 (implied upside +3.63%) and a tactical target of INR 28.00 (implied upside +13.82%) while a protective stop under INR 20.50 reduces downside risk. For liquidity-sensitive positions, scale size and monitor on-book depth before entering; see the Panjon company page on Meyka for live metrics: Panjon on Meyka.

Final Thoughts

PANJON.BO stock is a pre-market top gainer on 23 Jan 2026 after a strong volume-driven move to INR 24.61, marking a clear momentum event on the BSE in India. Fundamentals show conservative balance-sheet metrics — current ratio 2.75, debt-to-equity 0.21 — but profitability remains modest with EPS INR 0.42 and PE 58.60, so valuation appears rich. Meyka AI rates PANJON.BO at 61.34/100 (Grade B, HOLD) and Meyka AI’s forecast model projects a yearly figure of INR 24.16, implying a model-based downside of -1.86% versus the current price; forecasts are model-based projections and not guarantees. Traders should weigh the momentum trade against limited liquidity and narrow margins: consider small, staged positions with a stop near INR 20.50, and targets at INR 25.50 (near-term) and INR 28.00 (tactical). For context on sector moves, compare listed healthcare names and monitor company releases or distributor updates that can change risk/reward quickly. Sources: Investing.com market pages and Investing.com company pages. Meyka AI provides AI-powered market analysis for real-time signals and grading.

FAQs

Why did PANJON.BO stock spike in pre-market trading?

The pre-market spike to INR 24.61 reflects heavy volume of 170,620 shares versus avg 14,086, suggesting momentum buying. With no major public earnings surprise, the move is likely trader-driven and linked to liquidity and short-term positioning.

What are realistic price targets for PANJON.BO stock?

We outline a near-term target of INR 25.50 and a tactical target of INR 28.00. Use a stop under INR 20.50 to limit downside; adjust targets if liquidity or fundamentals change.

How does Meyka AI rate PANJON.BO stock and what does it mean?

Meyka AI rates PANJON.BO 61.34/100 (Grade B, HOLD). This considers benchmark and sector comparisons, financial metrics, growth and analyst inputs. It is informational and not investment advice.

What key risks should investors watch for PANJON.BO stock?

Main risks include thin liquidity, high trailing PE 58.60, low net margin 1.61%, and reliance on distributor or product updates. Price can move sharply on small order flows.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *